I Spent Six Weeks Investigating Why Hundreds of Women in Their Forties Are All Describing the Same Exhaustion — and Why Their Doctors Keep Missing It
The molecule behind it isn't a hormone. It isn't on any standard blood panel. And the research explaining exactly what it does — and why it crashes during perimenopause — has been sitting in peer-reviewed journals for years.
Perimenopausal women consistently report exhaustion that standard bloodwork does not explain — a gap that functional medicine practitioners are only now beginning to address systematically.
I started getting messages about a year ago. Not from doctors. From women.
They found me through the piece I wrote about the perimenopause diagnosis gap — the well-documented phenomenon where women in their early forties spend months, sometimes years, being told their bloodwork is normal while their bodies are telling them something else entirely. The messages had a pattern I couldn't ignore.
Same age range. Same specific fatigue — not ordinary tiredness, something they described as cellular, structural, like the power had been cut at the source. Same sequence of failed solutions. And the same encounter that changed everything: a conversation with someone who mentioned something their OB-GYN had never brought up, something they'd never heard of before, that explained every single thing they'd been experiencing.
The molecule was called NAD+.
I'm a health researcher and medical writer. I know enough to be skeptical of supplement narratives. I also know enough to take seriously when the same mechanistic explanation — rooted in actual published science — keeps appearing independently across dozens of women with no connection to each other.
So I did what I do. I followed the research.
What the Standard Workup Is Actually Missing
Let me start with the biology, because the biology is where the whole story lives.
Every cell in your body runs on energy. That energy is produced inside mitochondria — the structures you may remember from high school biology as the "powerhouses of the cell." Mitochondria take what you give them — food, oxygen, sleep — and convert it into usable cellular fuel, a molecule called ATP. ATP is the currency your body spends on everything: moving a muscle, firing a neuron, repairing tissue, regulating a hormone.
Mitochondria cannot do this without NAD+. Not less efficiently. Not at reduced capacity. Without adequate NAD+, the entire energy conversion process stalls. NAD+ is the essential cofactor — the key the engine requires to run.
"Without adequate NAD+, mitochondria cannot produce energy efficiently — regardless of how much you sleep, how clean you eat, or how many supplements you take."
Here is what the research establishes with consistency across multiple peer-reviewed institutions: NAD+ levels decline significantly with age. By the time most women reach 45, NAD+ levels have fallen to roughly half of what they were at 25. The decline is not gradual and linear — it accelerates. The drop between 40 and 50 is steeper than the drop between 25 and 40.
And here is the part that took me longest to fully understand, even though it was sitting in published papers: in women, this decline is not simply an age effect. It is directly linked to perimenopause.
The Estrogen–NAD+ Connection Nobody Explains
Estrogen's most discussed role is regulating the menstrual cycle. What is almost never explained — not in annual OB-GYN visits, not in the standard perimenopause literature — is that estrogen also governs NAD+ biosynthesis.
Biosynthesis means production. Your body manufactures its own NAD+ through enzymatic pathways that are, in part, regulated by estrogen. When estrogen begins to fluctuate in your early forties — which is, at its most basic level, what perimenopause is — those production pathways are disrupted. NAD+ output drops. Mitochondrial function declines. Cellular energy production falls.
A 2023 paper published in the International Journal of Molecular Sciences documented this relationship between estrogen decline and NAD+ biosynthesis in detail. A 2024 study published in MedComm demonstrated that NAD+ levels in aging ovarian tissue decline measurably with age — and that NMN supplementation restored those levels, improving mitochondrial function, hormone secretion, and inflammatory markers in the process.
The 2021 clinical study published in Science is the most frequently cited in this space for good reason: it examined postmenopausal women with prediabetes and found that NMN supplementation increased muscle insulin sensitivity by 25% — without any changes to diet or exercise. The mechanism, the researchers explained, was the restoration of NAD+ availability in muscle tissue, which had been depleted by the hormonal changes of menopause.
Perimenopausal fatigue is not primarily a mood issue or a sleep issue. It is a documented, measurable cellular energy shortage — with a mechanism that is understood, a timeline that corresponds almost precisely to when women begin reporting that nothing restores them anymore, and an intervention that addresses it directly.
And here is the part that makes so many women angry when they finally hear it: NAD+ is not included in standard bloodwork. It never has been. The panels your OB-GYN orders — TSH, CBC, iron, vitamin D, metabolic panel — were built around a model of how the body works that predates our current understanding of cellular energy by decades. You can be profoundly depleted and receive results that say everything is normal — because they tested everything except the thing that was actually failing.
"Normal labs do not mean nothing is wrong," one functional medicine physician told me during my research. "They mean nothing is wrong with what was tested. That's a crucial distinction — and for perimenopausal women, it's a distinction that costs years."
Why the Supplements You Already Tried Didn't Work
Almost every woman I spoke with had already tried a version of the same list before finding this. Ashwagandha. Magnesium. B-complex. Vitamin D. Iron even when their iron was fine. A multi-symptom menopause blend with eleven ingredients.
Some helped at the margins. Most did nothing meaningful.
The reason is not that these supplements are ineffective. It's that they are addressing the wrong level of the problem.
Ashwagandha works on cortisol — the stress hormone. Magnesium supports sleep architecture. B vitamins assist specific metabolic pathways. None of them address NAD+ production. None of them communicate with mitochondria. You were treating the signals of a failing power plant without ever looking at the power plant itself.
"You were treating the signals of a failing power plant without looking at the power plant itself. Ashwagandha can't fix a cellular fuel shortage. Neither can sleep."
This is also why more sleep doesn't fix it. Caffeine doesn't fix it. Willpower absolutely doesn't fix it. These are all downstream interventions. They work on what the body does with energy. They do nothing about whether the cells are actually able to produce energy in the first place.
What I Found When I Followed the Research
Six weeks of reading primary sources, functional medicine literature, and clinical trial data left me with a consistent picture. The mechanism is sound. The NAD+–estrogen relationship is documented across multiple independent institutions. The safety profile of NMN supplementation in human trials is clean. The timeline of effect — minimal in week one, first signals in week two, meaningful results emerging between weeks three and six — is consistent across both clinical data and the women I spoke with.
I also found something the supplement industry largely fails to communicate clearly: NMN works through a specific cellular transport mechanism. A transporter protein called Slc12a8 was confirmed in the past several years to allow cells to take up NMN directly and convert it into NAD+ rapidly. This is not stimulation. It is not borrowing from tomorrow. It is giving depleted mitochondria the specific raw material they have been running short of since estrogen began its decline.
The women reporting results are not, in the language of research, experiencing placebo effects that can be explained by week-long timeline variation. They are describing a specific, progressive, reproducible pattern of cellular restoration that maps almost exactly onto what the biology predicts.
One detail I found particularly significant: in multiple accounts and in the clinical literature, cognitive improvement tends to precede physical energy recovery. Brain fog lifts before stamina returns. This is consistent with what we know about mitochondrial concentration in neural tissue — the brain is extraordinarily energy-hungry, and NAD+ restoration appears to show up there first.
What the Timeline Actually Looks Like
Based on both clinical trial data and the accounts of multiple women who agreed to share their experience in detail, here is the honest progression:
In Their Own Words
"My brain fog lifted before the physical energy did. I could follow a conversation at work without that underwater feeling. Week 3. I hadn't had that in two years."
"I didn't tell my husband I was trying something new. Week 3 he asked me — out of nowhere — if I was feeling better. He just noticed. I started crying in the kitchen."
"I'm a nurse. I read the studies and I was frustrated with myself for not looking in this direction sooner. Week 3, same as the others. The clarity came first. I could finish a twelve-hour shift without the underwater feeling I'd been calling 'just getting older.' I wasn't getting older faster. I was depleted."
"I had started to think maybe this was just aging and I needed to accept it. I have a really hard time describing what it feels like to realize that isn't true."
The Questions Worth Asking Before You Try Anything
After six weeks of research, these are the practical questions I'd want answered — and the honest answers based on the available evidence:
The Decision
There are two positions you can be in after reading this.
The first: you've been through the bloodwork, the normal results, the supplements that didn't quite get there — and something in what you've just read corresponds to your experience in a way that feels specific and real. In that case, the research is pointing you toward something worth trying.
The second: you're skeptical, and that skepticism is earned. A 60-day money-back guarantee exists precisely because skepticism is rational here. You don't have to decide whether this works before you've experienced it. You just have to give it the time the mechanism requires.
What I can tell you after six weeks of following this research: the science is real, the mechanism is documented, and the women describing results are not describing a supplement that made them feel vaguely better. They are describing the specific, progressive return of something they had been quietly grieving for a year or two — their own energy, their own cognitive presence, their own capacity.
They describe it with the same word, over and over.
Normal.
Not superhuman. Not transformed beyond recognition. Just themselves — the version that existed before perimenopause began quietly cutting the power.